Who Is James Sackl? Inside the Melbourne Founder's Portfolio

James Sackl is a Melbourne-based founder building two ventures at very different ends of the deep-tech spectrum: one focused on human biology, the other on energy and industrial resources. Operating out of Cremorne, Victoria, Sackl has spent more than six years building startups, with a track record that includes an early advertising venture, a pandemic-era medical device, and now two Singapore-domiciled companies aimed at long-horizon problems.

An Unconventional Start

Sackl's entrepreneurial path began early. At 21, he founded a company by walking door to door in Melbourne, pitching advertising space on a website that did not yet exist, and banked $21,000 in pre-orders before writing a single line of code. That venture, Young Media, ran from 2007 to 2012 out of Singapore, and Sackl describes it as a successful exit.

During the COVID-19 pandemic, Sackl turned his attention to healthcare technology, designing an all-in-one rapid antigen test pen that went on to generate $130 million in sales. That project marked a shift toward the biotech and health-focused work that would come to define his next ventures.

Wallace Biotechnologies: A Multi-Decade Bet on Health Span

Founded in September 2020, Wallace Biotechnologies is a Singapore-domiciled biotech company being built to extend human health span and environmental health over a multi-decade horizon. The company describes its mission as developing technologies to harness biology to enhance human health, with an ambition to build what it calls the largest biodata bank ever assembled, paired with AI systems designed to better understand biological systems.

Terraform Technologies: Cheap Resources at Scale

Sackl's second venture, Terraform Technologies, founded in November 2020, takes a different approach entirely, aiming to harness solar energy to produce low-cost resources at industrial scale. The company describes its mission as engineering systems that convert free fusion energy, primarily sunlight, into useful materials and output anywhere it's needed.

In August 2026, Terraform Technologies began a design, engineering, site-assessment, and commercial-feasibility program evaluating modular, solar-powered production systems for converting raw feedstock into housing-material production. Sackl developed the program to evaluate whether changes in energy and computing costs can support additional production approaches. Wallace Biotechnologies, notably, is a separate venture and is not participating in, financing, or operating the Terraform program.

The company has also discussed plans to pursue a capital raise of around AUD $100 million in mid-2027 to support its growth.

Writing Under the Golden Age Banner

Beyond his companies, Sackl publishes long-form essays under a project called Golden Age, described as a public archive of writing on thinking, execution, and resilience aimed at the generation inheriting what he calls the most resourced era in history. One recent essay challenged conventional Australian financial advice around saving, arguing instead that defending one's time is more valuable than saving money, a theme Sackl has also discussed publicly, including in a podcast appearance on Diary of an ADHD Strategist, where he spoke about neurodivergence, pattern recognition, and the practical challenge of turning ideas into execution.

Taken together, Sackl's portfolio, spanning biotechnology, energy infrastructure, and public writing, reflects a founder betting on long-horizon, capital-intensive problems rather than the faster-moving startup categories more commonly associated with early-stage entrepreneurship.